If you have a different MOA and also a different potency approach then you are fine to say what you say but what are the chances of that? Right now NIL on both requirements.
You are years away from such being the key element anyway so get to it.
- Forums
- ASX - By Stock
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

If you have a different MOA and also a different potency...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.5¢ | 17.0¢ | 16.5¢ | $39.66K | 238.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 277684 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 14285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 277684 | 0.165 |
6 | 607381 | 0.160 |
3 | 26451 | 0.155 |
3 | 115000 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 14285 | 1 |
0.180 | 108494 | 4 |
0.185 | 94565 | 3 |
0.190 | 133868 | 2 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |